Journal
NEUROIMAGING CLINICS OF NORTH AMERICA
Volume 13, Issue 4, Pages 769-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S1052-5149(03)00099-6
Keywords
-
Ask authors/readers for more resources
Positron emission tomography (PET) imaging has been used extensively over the past 20 years for investigations of Alzheimer's disease and other dementing disorders, from pathophysiology to diagnosis. This article reviews clinical applications of PET imaging in dementia, particularly the use of [F-18]fluordeoxyglucose (FDG), and evidence from the literature concerning the efficacy of FDG PET imaging in dementia diagnosis and care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
